APOE and diabetes mellitus: Other limitations include unknown group differences in the risk factors of cognitive decline and AD, such as apolipoprotein E ε4 genotypes [46], and inflammation [47], although there were no significant differences between the groups in hypertension, diabetes mellitus, medications, biomarkers of lipid metabolism, physical performance, instrumental ADL functioning, and depressive moods.